Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-19-016 from the NIH Guide for Grants and Contracts. The FOA will focus on fusion oncoproteins found in tumors that have high risk of treatment failure and for which there has been little progress in identifying targeted agents. Responsive applications can focus on any fusion oncoprotein in pediatric solid tumors or on NUP98 fusion proteins that occur in young children with acute myelogenous leukemia (AML). However, greater preference will be given to applications focused on PAX-FOXO (alveolar rhabdomyosarcoma), C11orf95RELA (ependymoma), or NUP98 fusion proteins. (Source: NIH Funding Opportuni...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2018 Category: Research Source Type: funding
Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp)
Funding Opportunity ID: 291452 Opportunity Number: PA-17-138 Opportunity Title: Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: EducationHealthCategory Explanation: CFDA Number(s): 93.396Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Education Health Source Type: funding
Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp)
Funding Opportunity PA-17-138 from the NIH Guide for Grants and Contracts. This Administrative Supplement funding opportunity announcement is part of the Cancer Moonshot initiative to accelerate cancer research, and was developed in response to a recommendation from the Blue Ribbon Panel of experts charged with advising the National Cancer Advisory Board on the exceptional scientific opportunities that could be accelerated through this initiative. Based on the recommendation to intensify research and form highly dynamic and collaborative networks of investigators to advance our understanding of fusion oncoproteins as dr...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 26, 2017 Category: Research Source Type: funding
An Opportunity to Collaborate and Use the Unique Resources of the NIH Clinical Center
Three years ago, NIH created a program to enable extramural researchers to collaborate with our intramural scientists and use the exceptional resources of the NIH Clinical Center. Since then, 20 awards have been made to support projects of significant breadth, such as a trial for treatment of relapsed leukemia; a malaria vaccine trial; and a trial testing a new cardiac catheter. This is the fourth year that NIH has issued this funding opportunity. The December 15 pre-application deadline is approaching, and I wanted to remind you what this program offers.
As described in the funding opportunity announcements (FOAs) (PAR 15...
Source: NIH Extramural Nexus - November 18, 2015 Category: Research Authors: Mike Lauer Tags: blog Open Mike Award Programs Clinical Center Source Type: funding
Request for Proposals: Leukemia & Lymphoma Society Transforming CURES Initiative (TCI) - Intercepting Progression to Advanced Myeloid Blood Cancers
Request for Proposals: Leukemia & Lymphoma Society Transforming CURES Initiative (TCI) - Intercepting Progression to Advanced Myeloid Blood Cancers The Leukemia & Lymphoma Society (LLS) is proud to announce the "Transforming CURES Initiative (TCI) - Intercepting Progression to Advanced Myeloid Blood Cancers," a new Request for Proposals (RFP) to identify and develop novel, safe and effective treatment paradigms for patients with hematological malignancies. The near term goal of this program is to advance the scientific and medical understanding of myeloid disease progression from an early stage to fra...
Source: ScanGrants feed - November 17, 2014 Category: Research Authors: Leukemia & Lymphoma Society Source Type: funding
Trish Greene Memorial Quality of Life Lectureship
Deadline: September 30, 2014 Award: A $2,000.00 award, a plaque, and travel reimbursement to attend the Opening Ceremonies at ONS Congress. The paper will be published in the Clinical Journal of Oncology Nursing. Purpose: This award was established to focus attention of the membership on quality-of-life issues in cancer care; describe the contributions of clinicians, educators, administrators, and researchers in oncology nursing to quality of life in cancer care; apply information related to quality of life to oncology nursing practice; and incorporate the philosophy of quality of life into all aspects of canc...
Source: ScanGrants feed - September 15, 2014 Category: Research Authors: Oncology Nursing Society Source Type: funding
Oncology Nursing Society Clinical Lectureship
Deadline: September 30, 2014 Award: A $2,000 award, a plaque, and travel reimbursement to attend the Opening Ceremonies at ONS Congress. The paper will be published in the Clinical Journal of Oncology Nursing. Purpose: To recognize and support excellence in clinical nursing practice. The lecture is presented at the ONS Annual Congress. Nominee's Eligibility Criteria: The candidate must meet the following criteria: • Be a registered professional nurse and an active ONS member • Have a minimum of two years experience in oncology nursing • Be a recognized expert in clinical ...
Source: ScanGrants feed - September 15, 2014 Category: Research Authors: Oncology Nursing Society Source Type: funding
Excellence in Radiation Therapy Nursing Award
Deadline: September 30, 2014 Award: A $250 award, a plaque, and travel reimbursement to attend the Opening Ceremonies at ONS Congress. Purpose: To recognize and support excellence in radiation therapy nursing. Nominee's Eligibility Criteria: The candidate must meet the following criteria: • ONS awards policies do not permit self-nominations for this award. To be considered eligible for this award, the nominee must be nominated by an ONS member in good standing. If you have questions regarding eligibility requirements please contact awards@ons.org. • Be a registered professional nu...
Source: ScanGrants feed - September 15, 2014 Category: Research Authors: Oncology Nursing Society Source Type: funding
Pediatric Preclinical Testing Consortium: Research Programs (U01)
Funding Opportunity Number: RFA-CA-14-018 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthCFDA Number: 93.395Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 50...
Source: Grants.gov - September 6, 2014 Category: Research Tags: Education Health Source Type: funding
Pediatric Preclinical Testing Consortium: Research Programs (U01)
Funding Opportunity RFA-CA-14-018 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is for Research Programs for in vivo and in vitro testing of the activity of pediatric anticancer drug candidates. These Research Programs are the fundamental part of the Pediatric Preclinical Testing Consortium (PPTC) initiative, which also includes a PPTC Coordinating Center (supported under RFA-CA-14-019). The main goal for PPTC is to develop a rigorous preclinical testing system for pediatric anticancer drug candidates and to generate reliable data that can be used to inform new agent priorit...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 5, 2014 Category: Research Source Type: funding
Shwachman-Diamond Syndrome Foundation Research Grant Program
Shwachman-Diamond Syndrome (SDS) is a multi-system autosomal-recessive disorder characterized by exocrine pancreatic dysfunction, and varying degrees of marrow dysfunction with cytopenias. Many associated clinical problems have also been described, including skeletal anomalies, metaphyseal dysostosis, rib abnormalities, cleft palate, dental abnormalities and others. Shwachman-Diamond Syndrome Foundation (SDSF) is a nonprofit support organization actively helping the victims of this disease. SDSF is accepting grant requests for research relevant to this disease. Any high quality, innovative research proposal deemed rel...
Source: ScanGrants feed - June 25, 2014 Category: Research Authors: Shwachman-Diamond Syndrome Foundation Source Type: funding
Leukemia & Lymphoma Society Quest for Cures Request for Proposals
Leukemia & Lymphoma Society Quest for Cures Request for Proposals Letter of Intent Deadline: June 3, 2014, 3:00 PM ET This RFP represents a new LLS research grant paradigm; QFC projects should, if successful, have a measurable impact on the diagnosis or treatment of patients with hematologic malignancies over the next 5 to 10 years. Proposals must include specific timelines, milestones and deliverables that researchers believe are achievable with their proposed funding. The range of funding available is from $200,000 to $400,000 annually, for research to be completed in a period of 2 years. Additional fund...
Source: ScanGrants feed - May 1, 2014 Category: Research Authors: Leukemia & Lymphoma Society Source Type: funding
Children’s Leukemia Research Association Research Grant Program
The objectives of this committee are to direct the funds of the Association into the most promising projects, and where funding would not duplicate other funding sources. With your help, we are getting closer every day! Because of the support of friends like you, the scientific community is making incredible strides in developing chemotherapy regimens that are extending the lives of leukemia patients. Not everyone under treatment goes into remission but our research grants are funding the examinations into why this is so, and how we can continue to combat leukemia. How the CLRA Research Grant Program Works Any ...
Source: ScanGrants feed - January 13, 2014 Category: Research Authors: Children’s Leukemia Research Association Source Type: funding
American Society of Hematology Research Training Award for Fellows
Audience: Junior Investigator award for second and third-year fellows in the United States or Canada. Award Amount: $55,000 Purpose: To allow fellows in training the benefit of protected time for research for one year Audience: Senior Investigator award for fourth and fifth-year fellows in the United States or Canada Award Amount: $55,000 Purpose: To allow fellows in training the benefit of protected time for research for one year The ASH Research Training Award for Fellows (RTAF) is designed to encourage junior researchers in hematology, hematology/oncology, or other hematology-related trai...
Source: ScanGrants feed - December 4, 2013 Category: Research Authors: American Society of Hematology Source Type: funding
